| Patent # | Description |
|---|---|
| US-5,580,796 |
Method for fabricating thin film transistor matrix device A thin film transistor matrix device comprises a transparent insulating substrate, a thin film transistor unit, a picture element unit, a storage capacitance... |
| US-5,580,795 |
Fabrication method for integrated structure such as photoconductive
impedance-matched infrared detector with... A photoconductive isotype heterojunction impedance-matched infrared detector has blocking contacts which are positioned on the bottom side of the detector. The... |
| US-5,580,794 |
Disposable electronic assay device A disposable electronic assay device comprising card-like housing containing a sample receptor for receiving a sample of body fluid containing an analyte to be... |
| US-5,580,793 |
Process and device for determining the para content of a hydrogen gas
stream Process and device for determining para content X.sub.1 of a hydrogen gas stream, in which temperature T.sub.1 as well as pressure p.sub.1 of the hydrogen gas... |
| US-5,580,792 |
Method of removing a catalyst substance from the channel region of a TFT
after crystallization Method of fabricating a semiconductor device, such as a thin-film transistor, having improved characteristics and improved reliability. The method is initiated... |
| US-5,580,791 |
Assay of water pollutants A method of assay of antioxidant activity of a sample of water, which comprises monitoring the change exerted by the sample on a luminescent reaction. |
| US-5,580,790 |
Method and apparatus for processing fluids Embodiments of the present invention feature a multilchambered cuvette having a first movement pattern and a second movement pattern, the first movement pattern... |
| US-5,580,789 |
Method for collecting blood A process is disclosed for the production of an anticoagulant composition which allows for the accurate analysis of blood electrolyte concentrations. Also... |
| US-5,580,788 |
Use of immunoglogulin-binding artificial proteins as molecular weight
markers The present invention relates to immunoglobulin-binding artificial proteins (repetitively linked-proteins) which result when either one of or several numbers of... |
| US-5,580,787 |
Cloning vector for use in lactic acid bacteria A recombinant plasmid useful as a cloning vector in lactic acid bacteria and only containing DNA of lactic acid bacterial origin, the plasmid comprising (a) a... |
| US-5,580,786 |
Dual chamber blood culture bottle with syringe capture and piston
assembly A multi-chambered blood culture device for simultaneously conducting two blood culture tests on a single blood sample. An integrated unit is provided with a... |
| US-5,580,785 |
Field-portable toxicity tester A portable toxicity tester for use in the field using bioluminescent organisms consisting of a light tight container for housing the necessary flash of light... |
| US-5,580,784 |
Data collection apparatus for use with chemical sensors An apparatus utilizing chemical sensors to determine whether a particular sample vial is evidencing bacterial growth includes directing radiation sources having... |
| US-5,580,783 |
Enzymatic process for the preparation of chiral .alpha.-tertiary
carboxylic acid esters This invention provides a process for enrichment of enantiomers of .alpha.-tertiary carboxylic acid esters from mixtures of corresponding esters using a... |
| US-5,580,782 |
Acetic acid bacterium, plasmid derived from said bacterium and shuttle
vectors constructed with said plasmid Acetobacter sp. strain BPR 2001, an endogeneous plasmid named pAH4 derived from said strain as well as shuttle vectors constructed from said plasmid and an E.... |
| US-5,580,781 |
Three-dimensional tumor cell and tissue culture system The present invention relates to a three-dimensional cell culture system which can be used to culture a variety of different cells and tissues in vitro for... |
| US-5,580,780 |
Vascular adhesion protein-(VAP-1) and VAP-1-specific antibodies A novel endothelial cell molecule, VAP-1, is described that mediates lymphocyte binding in man. Further described are anti-VAP-1 monoclonal antibodies and... |
| US-5,580,779 |
Method for inducing human myocardial cell proliferation The present invention relates to a method for inducing myocardial cell proliferation. It is based, at least in part, on the discovery that adult human myocardial... |
| US-5,580,778 |
Isolation and diagnosis of coronaviruses as a factor in bovine shipping
fever, and a cell line for culturing... Coronaviruses can be a significant factor in bovine shipping fever. A new human rectal tumor cell line, HRT-18G, is suitable as a host cell line for the... |
| US-5,580,777 |
Generation of neural precursor cell lines A method for the in vitro production of lines of immortalized neural precursor cells, including cell lines having neuronal and/or glial cell characteristics,... |
| US-5,580,776 |
Modified hepatocytes and uses therefor Genetically engineered or transduced hepatocytes which express genetic material of interest introduced or incorporated into them, as well as methods of... |
| US-5,580,775 |
High affinity, brain-specific nucleic acids encoding a L-proline
transporter, and vectors, and host cells... The anatomical distribution, nucleic acid sequence, pharmacological properties, and inferred structural features of a cDNA encoding a high affinity, Na.sup.+... |
| US-5,580,774 |
Chimeric antibodies directed against a human glycoprotein antigen The present invention discloses novel chimeric monoclonal antibodies, directed against proteoglycans of human melanoma cells, having antigen-specific variable... |
| US-5,580,773 |
Chimeric immunogenic gag-V3 virus-like particles of the human
immunodeficiency virus (HIV) An unprocessed human immunodeficiency virus 2 (HIV-2) gag precursor protein, containing a deficient protease, assembles into virus-like particles by budding... |
| US-5,580,772 |
Association between a novel human intracisternal A-type retroviral
particle-type II (HIAP-II) and idiopathic... The present invention relates to the discovery of a novel retroviral particle associated with idiopathic CD4+ T-lymphocytopenia (ICL). New methods of diagnosis... |
| US-5,580,771 |
DNA encoding mammalian phosphodiesterases The present invention relates to novel purified and isolated nucleotide sequences encoding mammalian Ca.sup.2+ /calmodulin stimulated phosphodiesterases... |
| US-5,580,770 |
Support containing particulate adsorbent and microorganisms for removal
of pollutants A biologically active support for removing pollutants from a fluid stream such as waste water is prepared. The support is formed of a polymeric foam substrate... |
| US-5,580,769 |
CD8.sup.+ cell antiviral factor A protein secreted by peripheral blood mononuclear specifically from CD8.sup.+ lymphocytes is purified and characterized here and designated CD8.sup.+ cell... |
| US-5,580,768 |
Method for the production of proteins in plant fluids A method of producing a genetically transformed fluid-producing plant comprises: i) inserting into the plant tissue a gene or gene fragment controlling the ... |
| US-5,580,767 |
Inhibition of influenza viruses by antisense oligonucleotides Compositions and methods are provided for the treatment and diagnosis of influenza virus infections. In accordance with preferred embodiments, oligonucleotides... |
| US-5,580,766 |
Retroviral vector particles for transducing non-proliferating cells Retroviral vector particles are provided which contain: 1) oncoretroviral gag, pol, and env proteins, including an oncoretroviral gag capsid protein which has... |
| US-5,580,765 |
Process for producing optically active a-hydroxycarboxylic acid having
phenyl group using gordona terrae A biological process for predominantly producing an optically active .alpha.-hydroxycarboxylic acid having a phenyl group directly from a racemic... |
| US-5,580,764 |
Process for microbial reduction producing
4(S)-hydroxy-6(S)methyl-thienopyran derivatives A compound of formula ##STR1## in which X is hydrogen or a group of formula --SO.sub.2 NH.sub.2 is reduced to the trans (4S,6S) form of the corresponding... |
| US-5,580,763 |
Method for fermentation production of xanthan gum A method for the fermentation production of xanthan gum which comprises the step of carrying out culture by using a water-soluble inorganic nitrogen component... |
| US-5,580,762 |
Method of producing an oligosaccharide of a higher polymerization degree The present invention is a method of producing an oligosaccharide of a higher polymerization degree by enzymatic hydrolyzing of a polysaccharide with a hydrolase... |
| US-5,580,761 |
Method of conferring resistance to immunodeficiency viral infection In accordance with the present invention, disclosed is a method of conferring, upon a host cell, resistance to retroviral infection by interfering with one or... |
| US-5,580,760 |
FUSE binding protein and cDNA therefor The Far Upstream Element (FUSE) of the human c-myc gene, stimulates expression in undifferentiated cells. A FUSE binding protein (FBP), also referred to as DROME... |
| US-5,580,759 |
Construction of recombinant DNA by exonuclease recession An exonuclease-based method for joining and/or constructing two or more DNA molecules. DNA fragments containing ends complementary to those of a vector or... |
| US-5,580,758 |
Nucleic acid encoding a signal peptide, a recombinant molecule
comprising the nucleic acid, methods of using... The invention relates to a nucleic acid encoding a signal peptide from Bordetella pertussis, a recombinant molecule comprising the signal peptide, and processes... |
| US-5,580,757 |
Cloning and expression of biologically active .alpha.-galactosidase A as
a fusion protein The present invention involves the production of large quantities of human .alpha.-Gal A by cloning and expressing the .alpha.-Gal A coding sequence in... |
| US-5,580,756 |
B7IG fusion protein The invention identifies the B7 antigen as a ligand that is reactive with the CD28 receptor on T cells. Fragments and derivatives of the B7 antigen and CD28... |
| US-5,580,755 |
Human pluripotent granulocyte colony-stimulating factor Disclosed are novel polypeptides possessing part or all of the primary structural conformation and one or more of the biological properties of a mammalian (e.g.,... |
| US-5,580,754 |
Nucleic acid encoding the progenitor B cell stimulating factor A progenitor B cell stimulating factor which promotes the formation of pre-B cells is described. DNA sequences encoding same and methods of production and... |
| US-5,580,753 |
DNA encoding the human cytokine, interleukin-9 The invention involves DNA molecules which encode a human protein of 144 amino acids, referred to as interleukin-9, or IL-9. The protein is an erythropoietic... |
| US-5,580,752 |
Tightly regulated expression system for eucaryotic cells The invention relates to an expression system which permits control of the levels of protein produced, and optionally provides production of the mature form of... |
| US-5,580,751 |
Process for the preparation of C-terminally amidated peptides A process for preparing C-terminally amidated peptides, Peptide-NH.sub.2, is presented. In a first step, a substrate component is reacted with a nucleophile... |
| US-5,580,750 |
Method for the diagnosis of multidrug resistance in living cells A method is described to determine multidrug resistance in living cells by laser scanning confocal fluorescence microscopy of doxorubicin in sensitive and... |
| US-5,580,749 |
Internal reference for chemically modified spheres A probe system for monitoring chemical activity of a target chemical in an environment has first and second marker compounds each bonded to a common substrate to... |
| US-5,580,748 |
Diagnostic tests for alzheimers disease The present invention is a method for the diagnosis of Alzheimer's disease using human cells. Specifically, the method detects differences between potassium... |
| US-5,580,747 |
Non-radioactive enzyme assay The present invention is directed to the assay and purification of proteins, and particularly to the non-radioactive assay and purification of protein kinases,... |